Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Medtronic
Citi
Cantor Fitzgerald
McKesson

Generated: August 24, 2019

DrugPatentWatch Database Preview

Teikoku Pharma Company Profile

  Try a free trial


See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for TEIKOKU PHARMA, and what generic alternatives to TEIKOKU PHARMA drugs are available?

TEIKOKU PHARMA has two approved drugs.

There are three US patents protecting TEIKOKU PHARMA drugs.

There are twenty patent family members on TEIKOKU PHARMA drugs in eighteen countries and three supplementary protection certificates in three countries.

Summary for Teikoku Pharma
International Patents:20
US Patents:3
Tradenames:2
Ingredients:2
NDAs:2
Patent Litigation for Teikoku Pharma: See patent lawsuits for Teikoku Pharma

Drugs and US Patents for Teikoku Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teikoku Pharma DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-002 Dec 22, 2015 AP RX No No 9,308,195 ➤ Sign Up Y ➤ Sign Up
Teikoku Pharma DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-003 Dec 22, 2015 AP RX No No 9,308,195 ➤ Sign Up Y ➤ Sign Up
Teikoku Pharma DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-003 Dec 22, 2015 AP RX No No 8,940,786 ➤ Sign Up Y ➤ Sign Up
Teikoku Pharma DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-003 Dec 22, 2015 AP RX No No 9,763,880 ➤ Sign Up ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for Teikoku Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 5,411,738 ➤ Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 5,709,869 ➤ Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 5,589,180 ➤ Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 5,827,529 ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for TEIKOKU PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Patch 5% ➤ Subscribe 2009-11-13

Supplementary Protection Certificates for Teikoku Pharma Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1667986 92172 Luxembourg ➤ Sign Up PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
1667986 28/2013 Austria ➤ Sign Up PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317
0253738 C960002 Netherlands ➤ Sign Up PRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Boehringer Ingelheim
Federal Trade Commission
Deloitte
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.